News Release - Callout Image

 

News Room

This page is designed to provide you with quick and easy access to key information about King Pharmaceuticals. Here you will find an archive of King news releases, information about our company and leaders and how to reach us.
If you cannot find what you’re looking for, please contact our Corporate Affairs department at 908-429-8350.

01/21/2009 King Pharmaceuticals Reports Intent to Appeal Skelaxin® Summary Judgment Order
01/12/2009 King Pharmaceuticals to Present at JPMorgan Healthcare Conference
01/02/2009 New Drug Application Submitted For Acurox® Tablets
12/31/2008 King Pharmaceuticals Provides Update on Embeda™ NDA Review
12/30/2008 King Completes Acquisition of Alpharma
12/26/2008 King Pharmaceuticals Initiates Phase II Clinical Trial Evaluating T-62 as a Treatment for Neuropathic Pain
12/26/2008 U.S. Federal Trade Commission Provisionally Accepts Consent Decree and Terminates Waiting Period for King Pharmaceuticals’ Acquisition of Alpharma
12/22/2008 King Extends Tender Offer for Alpharma
12/18/2008 King Pharmaceuticals Announces Submission of New Drug Application For CorVue™
12/11/2008 Pain Therapeutics Receives Complete Response Letter from FDA for Remoxy®

 

pdf icon

Documents marked with this icon are presented in Portable Document Format (PDF) to retain the original format. To view or print this document, you must use the Adobe® Acrobat® Reader®. Acrobat® Reader® is free and available directly from Adobe’s Web site with full installation instructions. You can either view and print this document or save it to your computer’s hard drive to open later. Your method may vary depending on your operating system and browser type.

Get Acrobat

“Adobe” and “the Adobe logo” are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States and/or other countries.